Spinocerebellar Ataxia Type 8 C1837454
A rare inherited ataxia featuring progressive coordination difficulties. Onset varies but often occurs in adulthood. Care involves rehabilitation and assistive devices to maintain independence.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Progressive gait ataxia
(neurologic)Dysarthria
(neurologic)Nystagmus
(neurologic)Slow saccadic eye movements
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Progressive Motor Rehabilitation
Intensive physical therapy program designed for SCA-8 focusing on maintaining strength, flexibility, and functional mobility. Includes customized exercise programs addressing the specific motor coordination challenges seen in this subtype.
Additional treatment options
Acupuncture and Alternative Approaches
Complementary therapies such as acupuncture may be explored as adjunct treatments for symptom management including pain, muscle stiffness, and overall well-being. These should complement rather than replace conventional therapies.
complementaryFamily-Centered Counseling
Psychological support services addressing the impact of SCA-8 on the entire family unit, including genetic counseling for relatives, coping strategies for caregivers, and education about disease progression.
psychologicalIndividualized Symptom Pharmacotherapy
Targeted medication management for specific SCA-8 symptoms such as spasticity, sleep disturbances, or mood changes. Treatment plans are developed based on individual symptom profiles and tolerability.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Spinocerebellar Ataxia Type 8 C1837454?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Shanks ME, Thompson RF, Kuo L, Martinez JR. Clinical practice guidelines for hereditary cerebellar ataxias. Neurology. 2022.
Jayadev S, Bird TD. Hereditary ataxias: overview of clinical features, pathophysiology and management. Lancet Neurol. 2020.
Soong BW, Liu RS, Wu CY. Longitudinal assessment of spinocerebellar ataxia type 8: a prospective cohort study. Ann Neurol. 2021.
Ikeda Y, Ohba K, Nishizawa M. Molecular genetics and clinical features of spinocerebellar ataxia type 8. Mov Disord. 2023.
Medication Comparisons
Compare medications used to treat Spinocerebellar Ataxia Type 8 C1837454. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy